Table 1: Ten-year survival in relation to various characteristics of patients.
| Characteristics | Number | Percentage | Ten-year DFS (%) |
|---|---|---|---|
| Grading | |||
| Good | 101 | 46% | 92 |
| Moderate | 64 | 28.8% | 65 |
| Poor | 28 | 12.6% | 60 |
| Not graded | 28 | 12.6% | 76 |
| FIGO Stage 1988 | |||
| IA | 102 | 46% | 91 |
| IB | 11 | 5% | 67 |
| IC | 82 | 36.9% | 72 |
| IIA | 23 | 10.4% | 46 |
| Risk Group | |||
| Low risk IA–IB G1 | 71 | 32% | 91 |
| Moderate risk IA–IB G2–G3–GX | 46 | 20.7% | 80 |
| High risk IC–IIA | 105 | 47.3% | 62 |
| Histological type | |||
| Serous | 71 | 32% | 78 |
| Mucinous | 63 | 28.4% | 84 |
| Endometrioid | 48 | 21.2% | 65 |
| Clear cell | 28 | 12.6% | 73 |
| Mixed epithelial | 8 | 3.6% | 76 |
| Other | 4 | 1.8% | 79 |
| Dense adhesions | |||
| Yes | 108 | 48.9% | 61 |
| No | 114 | 51.1% | 90 |
| Peritoneal cytology | |||
| Yes | 28 | 12.6% | 43 |
| No | 194 | 87.4% | 81 |
| Capsule rupture | |||
| Yes | 48 | 21.4% | 66 |
| No | 174 | 87.4% | 78 |
| Age at diagnosis | |||
| <54 | 125 | 56.3% | 84 |
| >54 | 97 | 43.7% | 66 |
| Pre-operatory CA125 | |||
| <60 UI/ml | 77 | 54.6% | 85 |
| >60 UI/ml | 64 | 45.4% | 76 |
| Patients non-IA G1 | |||
| Treated with chemotherapy | 113 | 72.9% | 69 |
| With taxanes | 45 | 37.8% | 84 |
| Without taxanes | 74 | 62.2% | 60 |
| Treated without chemotherapy | 42 | 27.1% | 65 |
| Lymphoadenectomy in moderate–high risk group | |||
| Yes | 41 | 27.1% | 76 |
| No | 110 | 72.9% | 62 |
| Second look in moderate–high risk group | |||
| Yes | 47 | 31.2% | 58 |
| No | 104 | 68.8% | 74 |